Arcturus Therapeutics Holdings Inc (ARCT)
17.06
+0.90
(+5.53%)
USD |
NASDAQ |
Nov 21, 16:00
17.03
-0.04
(-0.21%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2024 | 0.00 |
June 30, 2024 | 0.00 |
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.0714 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.2244 |
September 30, 2022 | 0.4101 |
June 30, 2022 | 0.3677 |
March 31, 2022 | 0.3437 |
December 31, 2021 | 0.2765 |
September 30, 2021 | 0.2347 |
June 30, 2021 | 0.2006 |
March 31, 2021 | 0.1738 |
December 31, 2020 | 0.0381 |
September 30, 2020 | 0.0576 |
June 30, 2020 | 0.1612 |
Date | Value |
---|---|
March 31, 2020 | 0.8849 |
December 31, 2019 | 0.5814 |
September 30, 2019 | 0.279 |
June 30, 2019 | 0.4617 |
March 31, 2019 | 1.565 |
December 31, 2018 | 0.7265 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.0843 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2023
0.8849
Maximum
Mar 2020
0.2013
Average
0.1675
Median
Debt to Equity Ratio Benchmarks
Fulcrum Therapeutics Inc | -- |
Bioventus Inc | 2.579 |
Liquidia Corp | 0.00 |
Pfizer Inc | 0.7219 |
AIM ImmunoTech Inc | 0.9382 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 370.65M |
Total Liabilities (Quarterly) | 108.79M |
Shareholders Equity (Quarterly) | 261.87M |
Current Ratio | 4.763 |